Current variables, definitions and endpoints of the European cardiovascular magnetic resonance registry.
BACKGROUND
Cardiovascular magnetic resonance (CMR) is increasingly used in daily clinical practice. However, little is known about its clinical utility such as image quality, safety and impact on patient management. In addition, there is limited information about the potential of CMR to acquire prognostic information.


METHODS
The European Cardiovascular Magnetic Resonance Registry (EuroCMR Registry) will consist of two parts: 1) Multicenter registry with consecutive enrolment of patients scanned in all participating European CMR centres using web based online case record forms. 2) Prospective clinical follow up of patients with suspected coronary artery disease (CAD) and hypertrophic cardiomyopathy (HCM) every 12 months after enrolment to assess prognostic data.


CONCLUSIONS
The EuroCMR Registry offers an opportunity to provide information about the clinical utility of routine CMR in a large number of cases and a diverse population. Furthermore it has the potential to gather information about the prognostic value of CMR in specific patient populations.
Wagner
Anja
A
Department of Cardiology, Hahnemann University Hospital, Drexel University College of Medicine, Philadelphia, USA. anja.wagner@gmail.com
Bruder
Oliver
O
Schneider
Steffen
S
Nothnagel
Detlev
D
Buser
Peter
P
Pons-Lado
Guillem
G
Dill
Thorsten
T
Hombach
Vinzenz
V
Lombardi
Massimo
M
van Rossum
Albert C
AC
Schwitter
Juerg
J
Senges
Jochen
J
Sabin
Georg V
GV
Sechtem
Udo
U
Mahrholdt
Heiko
H
Nagel
Eike
E
D002312:Cardiomyopathy, Hypertrophic / Q000175:diagnosis*; D003324:Coronary Artery Disease / Q000175:diagnosis*; D005060:Europe; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000009:adverse effects; D016347:Medical Records Systems, Computerized; D011237:Predictive Value of Tests; D011379:Prognosis; D011446:Prospective Studies; D012042:Registries; D012107:Research Design; D018570:Risk Assessment; D013997:Time Factors